Spyridon Papapetropoulos serves as Executive at Adamas Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Spyridon Papapetropoulos has executed 4 insider transactions totaling $30.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 24, 2021 involved transacting 20,975 shares valued at $0.
Spyridon Papapetropoulos currently holds 20,975 shares of Adamas Pharmaceuticals Inc (ADMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Spyridon Papapetropoulos has been a net buyer of ADMS stock. They have purchased $30.2K and sold $0 worth of shares.
Spyridon Papapetropoulos's most recent insider trade was on Nov 24, 2021, when they sold 20,975 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 11, 2021 | ADMS | $30.2K | Purchase | 5,975 | $5.06 | Discretionary |
| Nov 22, 2020 | ADMS | $0 | Award | 10,000 | $N/A | Discretionary |